Khin Ohnmr Kying,Zw Min Ltt,KywZw Lin, Aung PyePhyo

aNo(2)Military Hospital(500-Bedded),Yangon,Myanmar

bUniversity of Pharmacy,Yangon,Myanmar

cDefence Services Medical Academy,Yangon,Myanmar

dMilitary Institute of Nursing and Paramedical Sciences,Yangon,Myanmar

The effect of pharmaceutical care in the elderly patients with type 2 diabetes mellitus

Win Myat Mawa,*,Mi Mi Sawb,Theingi Kyawa, Khin Ohnmar Kyaingc,Zaw Min Lattd,KyawZaw Lind, Aung PyaePhyod

aNo(2)Military Hospital(500-Bedded),Yangon,Myanmar

bUniversity of Pharmacy,Yangon,Myanmar

cDefence Services Medical Academy,Yangon,Myanmar

dMilitary Institute of Nursing and Paramedical Sciences,Yangon,Myanmar

A R T I C L E I N F O

Article history:

Available online 25 November 2015

Pharmaceutical care

Type 2 diabetes mellitus

Quality of life

Clinical outcomes

Pharmaceutical care plays a crucial role in reducing mortality and morbidities of the patients.A hospital based quasiexperimental study was conducted with elderly patients with type 2 diabetes who attended at the diabetes clinic of No.(2) Military Hospital(500-Bedded)in Myanmar from April 2013 to February 2014.The aim of this study was to evaluate the effect of pharmaceutical care in elderly patients with type 2 diabetes mellitus.A total of 52 respondents enrolled in this study. The clinical outcomes and quality of life of patients before and eight months after intervention were assessed.Pharmaceutical care program was implemented as intervention.Of the total number of respondents,52 drug related problems were identifed.Biomedical measurements and quality of life scores of respondents were presented as the comparison between pre and post intervention measurements.In order to present comparative analysis of mean scores of outcome variables (biomedical measurements,quality of life)before and after intervention,paired t tests were used.According to results, capillary blood glucose,blood pressure,body mass index and waist circumference were signifcantly different(p<0.05).Postintervention mean of quality of life scores were signifcantly higher than that of pre-intervention mean scores at p level of 0.000.These fndings indicated that pharmaceutical care intervention could promote clinical outcomes and quality of life of elderly patients with type 2 diabetes mellitus.Hence,it is recommended that a better designed pharmaceutical care program and organizational structure of clinical pharmacy should be developed in hospitals.

Acknowledgements

The authors acknowledge Brigadier General Soe Win,Director,Directorate of Medical Service;Brigadier General Phone Myat, Commandant,Military Institute of Nursing and Paramedical Sciences;Brigadier General Sein Lin,Commandant,No.(2)Military Hospital(500-Bedded);and Professor Colonel KayThiHtun, Commander,Defence Services Obstetric Gynecological andChildren hospital for their kind permission and encouragement to do this research work.Thanks are also due to U Po Kya,President,Myanmar Pharmaceutical Association for the fnancial support.

R E F E R E N C E S

[1]Frier BM,Fisher M.Diabetes mellitus.In:Davidson’s principle and practice of medicine.2006.p.795–834[Chapter 21].

[2]Helper CD,Strand LM.Opportunities and responsibilities in pharmaceutical care.Am J Hosp Pharm 1990;47:533–543.

[3]Amor BL,Britton ML,Dennis VC,et al.A review of pharmacist contributions to diabetes care in the United States.J Pharm Pract 2010;23(3):250–264.

*E-mail address:laypyay1145@gmail.com.

Peer review under responsibility of Shenyang Pharmaceutical University.

http://dx.doi.org/10.1016/j.ajps.2015.11.119

1818-0876/?2016 Production and hosting by Elsevier B.V.on behalf of Shenyang Pharmaceutical University.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).